598-55-0

Applied Filters:

Keyword:'598-55-0'

Showing 1-1 of 1 result for "598-55-0" within Papers

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

Timo Mäkikallio et al.

Lancet (London, England), 388(10061), 2743-2752 (2016-11-05)

Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation in patients with left main coronary artery disease, but use of percutaneous coronary intervention (PCI) for this indication is increasing. We aimed to compare PCI and CABG for treatment

Page 1 of 1